Milvia Zambetti

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

Luca Gianni, W. Eiermann, Alexey Manikhas et al. · The Lancet · 2010 · 1.2K citations

Noah Trial, Breast Oncology, Oncology +7

Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-up

G. Bonadonna, Pinuccia Valagussa, Angela Moliterni et al. · New England Journal of Medicine · 1995 · 1K citations

Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast Cancer

Luca Gianni, Milvia Zambetti, Kim Clark et al. · Journal of Clinical Oncology · 2005 · 616 citations

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.

G. Bonadonna, Pinuccia Valagussa, Cristina Brambilla et al. · Journal of Clinical Oncology · 1998 · 566 citations

Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort

Luca Gianni, W. Eiermann, Aňa Lluch et al. · The Lancet Oncology · 2014 · 487 citations

Breast Oncology, Oncology, Superiority Trial +7